Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase IB Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

This study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab (Lunsumio) monotherapy in participants with relapse…

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Estimated

~$10 – $7,500

Hoffmann-La RocheNCT05091424